When GM differences were tested across sex and age groups for T3, we observed that participants aged <80 years had higher antibody levels as compared with those aged ≥80 years (GM = 4832.0 vs 3272.8 BAU/mL), but this association did not reach statistical significance ( P = .08).
← all excerpts
A Third Dose of mRNA COVID-19 Vaccine Significantly Enhances Anti-SARS-CoV-2 Spike IgG Response in Nursing Home Residents in Italy.
1
0.0800
0.0800